Editorial Note: Originally published in May 2025, this comprehensive resource has been updated to reflect the latest developments and newly available information concerning the state of United States foreign assistance and global health operations.
The landscape of United States foreign assistance has undergone a profound and historic transformation following a series of sweeping executive actions enacted by President Trump at the very start of his second term. These administrative decisions have fundamentally altered the architecture of international development, diplomacy, and global health outreach, creating widespread ripples across international partnerships and vulnerable populations worldwide. Among the most significant administrative directives was an executive order mandating an immediate, comprehensive 90-day review of all foreign aid programs. This directive was quickly followed by a strict stop-work order that effectively froze all ongoing payments, disbursements, and operational services for projects already underway across the globe.
The repercussions of these measures extended deep into the institutional framework of U.S. foreign aid delivery, most notably through the formal dissolution of the United States Agency for International Development (USAID). This monumental organizational dismantling involved the dramatic reduction of the agency’s workforce, affecting the vast majority of both staff members and external contractors who managed day-to-day operations in the field. Concurrently, the administration instituted the cancellation of a sweeping majority of existing foreign assistance awards, abruptly terminating contractual agreements that had supported various developmental and humanitarian initiatives for years.
While the administration did issue a specific waiver designed to permit the continuation of essential, life-saving humanitarian assistance, its practical application proved heavily restricted. The waiver was limited strictly to certain narrowly defined services, and program implementers reported significant bureaucratic hurdles and difficulties in successfully obtaining authorization to keep their projects afloat. In the wake of USAID’s dissolution, administrative responsibility for the remaining global health portfolios was transferred directly to the Department of State. Although several legal challenges have been filed in federal courts by advocacy groups, implementing partners, and affected stakeholders, there has been remarkably limited legal remedy or judicial relief secured to date. Consequently, vital U.S. global health programs have faced severe disruptions, and in numerous instances, have been permanently brought to an end. Looking ahead, impending changes to the Department of Health and Human Services, which include proposed budget cuts and structural reorganizations, are widely expected to exert additional pressure on these fragile programs. This detailed overview forms part of an ongoing series examining the shifting status and future viability of U.S. global health initiatives in a rapidly evolving political climate.
Background on U.S. Global Maternal and Child Health (MCH) Efforts
To fully understand the magnitude of the recent policy shifts, it is necessary to examine the historical foundation and strategic importance of United States global maternal and child health efforts. For decades, U.S. investments in MCH have served as a cornerstone of American foreign assistance, representing a bipartisan commitment to reducing preventable mortality and improving the health outcomes of mothers, newborns, and young children in low- and middle-income countries. These programs historically targeted the primary drivers of maternal and child mortality, including pregnancy-related complications, malnutrition, infectious diseases, and lack of access to basic clinical care during childbirth.
Through bilateral agreements, multilateral partnerships, and grants awarded to non-governmental organizations, faith-based groups, and academic institutions, U.S. funding helped build resilient health systems in regions with the highest burden of disease. Programs typically focused on expanding access to antenatal care, promoting skilled attendance at delivery, distributing micronutrients, supporting childhood immunization campaigns, and managing childhood illnesses such as pneumonia, diarrhea, and malaria. Over the years, these sustained investments yielded measurable progress, saving millions of lives and strengthening the healthcare infrastructure of partner nations, allowing local health workers to deliver essential services to marginalized and hard-to-reach communities.
Current Status of U.S. MCH Programs
The recent series of executive actions and administrative directives implemented by the administration has exerted a profound and immediate impact on the operational capacity and strategic continuity of U.S. Maternal and Child Health programs worldwide. Because MCH initiatives rely heavily on continuous funding streams, predictable supply chains, and robust local partnerships, the sudden imposition of the 90-day foreign aid review and the subsequent stop-work order paralyzed ongoing operations.
With the dissolution of USAID—which historically managed the lion’s share of bilateral MCH funding and technical oversight—the institutional knowledge and administrative framework dedicated to maternal and child wellbeing were severely fractured. The reduction of institutional staff and the cancellation of numerous assistance awards meant that many longstanding cooperative agreements between the U.S. government and international implementing partners were severed almost overnight. Although the transfer of remaining global health programs to the Department of State was intended to centralize oversight, the transition has been marked by administrative bottlenecks, uncertainty, and a lack of specialized personnel accustomed to managing complex clinical and community-level public health interventions. Implementing organizations have struggled to navigate the new bureaucratic requirements under the State Department while attempting to salvage whatever core activities remain permissible under the stringent waiver guidelines.
Impact on MCH Services and Outcomes
The combination of frozen funding, canceled awards, and the dismantling of USAID has translated into tangible disruptions in the delivery of essential maternal and child health services across numerous target countries. On the ground, clinics and community health outposts that depended on U.S. grants have reported acute shortages of critical medical supplies, pharmaceuticals, and nutritional supplements necessary for safe pregnancies and healthy childhood development.
Furthermore, the abrupt termination of programs has interrupted critical training initiatives for local healthcare workers, midwives, and community health volunteers who form the frontline of defense against maternal and infant mortality. Without reliable financial support and technical guidance, many community-based outreach efforts have ground to a halt, leaving vulnerable populations without access to vital preventive education, nutritional monitoring, and timely referrals for obstetric emergencies. Public health experts warn that these sudden operational halts threaten to reverse hard-won gains in global maternal and child survival, potentially leading to an uptick in preventable complications during childbirth, rising rates of childhood malnutrition, and increased vulnerability to infectious diseases among infants and young children living in resource-constrained settings.
What to Watch
As the situation continues to evolve, several critical developments and indicators warrant close observation by policymakers, global health advocates, and international observers. Foremost among these is the ongoing trajectory of legal challenges winding their way through the federal court system, which could potentially force a reevaluation of the executive branch’s authority over appropriated foreign assistance funds. Observers are also monitoring how the Department of State manages its expanded portfolio of global health responsibilities, particularly regarding whether additional waivers or administrative flexibilities will be introduced to ease the burden on surviving MCH projects.
Additionally, stakeholders will be closely watching the legislative branch to see how Congress responds to the restructuring of foreign aid during budget negotiations and oversight hearings. Lawmakers hold the constitutional power of the purse, and debates over foreign aid allocations and the future oversight of international development will likely remain a focal point of legislative friction. Finally, attention must be paid to proposed reorganizations and budget reductions within the Department of Health and Human Services, as any secondary cuts to domestic agencies that provide technical assistance to international programs could further erode the capacity of the U.S. government to support global maternal and child health in the future.
